Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Celiac Disease | 118 | 2024 | 821 | 20.090 |
Why?
|
Diet, Gluten-Free | 63 | 2024 | 285 | 9.590 |
Why?
|
Glutens | 32 | 2021 | 240 | 5.620 |
Why?
|
Colonoscopy | 17 | 2019 | 1409 | 2.430 |
Why?
|
Transglutaminases | 19 | 2021 | 200 | 2.000 |
Why?
|
Serologic Tests | 10 | 2019 | 382 | 1.690 |
Why?
|
Gastroenterology | 15 | 2022 | 593 | 1.570 |
Why?
|
Enterocolitis, Pseudomembranous | 7 | 2015 | 264 | 1.400 |
Why?
|
Gastrointestinal Agents | 6 | 2019 | 511 | 1.310 |
Why?
|
Patient Compliance | 16 | 2022 | 2697 | 1.270 |
Why?
|
Gliadin | 13 | 2021 | 80 | 1.160 |
Why?
|
Duodenum | 12 | 2023 | 495 | 1.130 |
Why?
|
Conscious Sedation | 3 | 2016 | 534 | 1.090 |
Why?
|
Endoscopy, Gastrointestinal | 13 | 2020 | 888 | 1.050 |
Why?
|
Gastrointestinal Hemorrhage | 5 | 2016 | 1126 | 1.010 |
Why?
|
Clostridium Infections | 7 | 2017 | 562 | 0.990 |
Why?
|
Intestinal Mucosa | 15 | 2023 | 3043 | 0.940 |
Why?
|
Adenoma | 8 | 2018 | 2155 | 0.930 |
Why?
|
Oligopeptides | 6 | 2018 | 1195 | 0.860 |
Why?
|
Methemoglobinemia | 2 | 2013 | 45 | 0.860 |
Why?
|
Immunoglobulin A | 16 | 2023 | 992 | 0.860 |
Why?
|
Autoantibodies | 15 | 2023 | 2114 | 0.830 |
Why?
|
Cost of Illness | 6 | 2020 | 1951 | 0.810 |
Why?
|
Gastric Juice | 1 | 2021 | 59 | 0.750 |
Why?
|
Anesthesia, Local | 2 | 2013 | 277 | 0.730 |
Why?
|
Capsule Endoscopy | 2 | 2023 | 106 | 0.700 |
Why?
|
HLA-DQ Antigens | 6 | 2020 | 190 | 0.680 |
Why?
|
Endopeptidases | 2 | 2021 | 762 | 0.650 |
Why?
|
Food Hypersensitivity | 5 | 2021 | 734 | 0.640 |
Why?
|
Biopsy | 20 | 2024 | 6777 | 0.640 |
Why?
|
Colonic Polyps | 4 | 2019 | 557 | 0.620 |
Why?
|
Humans | 200 | 2024 | 767040 | 0.610 |
Why?
|
Irritable Bowel Syndrome | 6 | 2017 | 454 | 0.590 |
Why?
|
Antidotes | 2 | 2016 | 138 | 0.590 |
Why?
|
Drug Evaluation | 2 | 2016 | 641 | 0.570 |
Why?
|
Midazolam | 2 | 2016 | 267 | 0.570 |
Why?
|
GTP-Binding Proteins | 9 | 2020 | 946 | 0.540 |
Why?
|
Gastrointestinal Diseases | 6 | 2017 | 1205 | 0.530 |
Why?
|
Anesthetics, Local | 2 | 2013 | 1005 | 0.530 |
Why?
|
Mesalamine | 2 | 2014 | 133 | 0.520 |
Why?
|
Colorectal Neoplasms | 8 | 2019 | 6966 | 0.520 |
Why?
|
Anti-Bacterial Agents | 10 | 2018 | 7469 | 0.510 |
Why?
|
Hypersensitivity | 2 | 2015 | 1169 | 0.510 |
Why?
|
Quality of Life | 8 | 2024 | 13485 | 0.510 |
Why?
|
Health Status | 4 | 2020 | 4091 | 0.510 |
Why?
|
Male | 113 | 2024 | 364203 | 0.510 |
Why?
|
Fentanyl | 2 | 2016 | 451 | 0.500 |
Why?
|
Capnography | 1 | 2016 | 90 | 0.490 |
Why?
|
Middle Aged | 87 | 2024 | 223233 | 0.490 |
Why?
|
Diarrhea | 6 | 2022 | 1319 | 0.490 |
Why?
|
Female | 115 | 2024 | 396660 | 0.490 |
Why?
|
Anti-Inflammatory Agents | 4 | 2020 | 1804 | 0.480 |
Why?
|
Adult | 85 | 2024 | 223317 | 0.470 |
Why?
|
Health Resources | 1 | 2020 | 948 | 0.460 |
Why?
|
Colonic Diseases | 1 | 2016 | 204 | 0.450 |
Why?
|
Radionuclide Imaging | 2 | 2016 | 1987 | 0.450 |
Why?
|
Colitis, Ulcerative | 4 | 2020 | 1924 | 0.450 |
Why?
|
Eosinophils | 2 | 2018 | 951 | 0.440 |
Why?
|
Triticum | 2 | 2012 | 92 | 0.440 |
Why?
|
Osteoporosis | 3 | 2022 | 1604 | 0.440 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 415 | 0.440 |
Why?
|
Eosinophilia | 1 | 2018 | 554 | 0.430 |
Why?
|
Hypnotics and Sedatives | 3 | 2016 | 1193 | 0.430 |
Why?
|
Deep Sedation | 1 | 2014 | 119 | 0.430 |
Why?
|
Budesonide | 4 | 2020 | 162 | 0.410 |
Why?
|
Inflammatory Bowel Diseases | 9 | 2022 | 2441 | 0.410 |
Why?
|
Ambulatory Care | 3 | 2020 | 2780 | 0.400 |
Why?
|
Alanine Transaminase | 1 | 2015 | 609 | 0.400 |
Why?
|
Severity of Illness Index | 13 | 2020 | 15925 | 0.370 |
Why?
|
Hospitalization | 6 | 2020 | 10815 | 0.370 |
Why?
|
Probiotics | 3 | 2016 | 387 | 0.370 |
Why?
|
Quality Improvement | 4 | 2019 | 3854 | 0.370 |
Why?
|
Narcotic Antagonists | 1 | 2016 | 591 | 0.360 |
Why?
|
Emergency Service, Hospital | 6 | 2020 | 7871 | 0.360 |
Why?
|
Congresses as Topic | 1 | 2015 | 812 | 0.350 |
Why?
|
Health Care Costs | 2 | 2020 | 3239 | 0.350 |
Why?
|
Withholding Treatment | 1 | 2014 | 619 | 0.350 |
Why?
|
Morbidity | 1 | 2015 | 1754 | 0.350 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2017 | 2270 | 0.340 |
Why?
|
Guideline Adherence | 6 | 2016 | 2232 | 0.340 |
Why?
|
Education, Medical, Undergraduate | 5 | 2017 | 1087 | 0.340 |
Why?
|
Young Adult | 36 | 2024 | 59980 | 0.330 |
Why?
|
Food Services | 1 | 2012 | 209 | 0.320 |
Why?
|
Ischemic Attack, Transient | 1 | 2014 | 874 | 0.320 |
Why?
|
Drug Approval | 1 | 2016 | 820 | 0.320 |
Why?
|
Drug Discovery | 2 | 2016 | 1068 | 0.310 |
Why?
|
Autoimmunity | 1 | 2016 | 1361 | 0.310 |
Why?
|
Abdominal Pain | 2 | 2019 | 1069 | 0.310 |
Why?
|
Practice Guidelines as Topic | 9 | 2016 | 7435 | 0.300 |
Why?
|
Aged | 57 | 2024 | 171319 | 0.300 |
Why?
|
Perception | 1 | 2014 | 1205 | 0.290 |
Why?
|
Teaching | 3 | 2017 | 1172 | 0.290 |
Why?
|
Reminder Systems | 1 | 2011 | 389 | 0.290 |
Why?
|
Medical Records | 5 | 2017 | 1409 | 0.280 |
Why?
|
Universities | 1 | 2012 | 1004 | 0.280 |
Why?
|
Gastroesophageal Reflux | 2 | 2014 | 834 | 0.280 |
Why?
|
Gastroparesis | 1 | 2009 | 143 | 0.270 |
Why?
|
Gastric Emptying | 1 | 2009 | 247 | 0.270 |
Why?
|
Aged, 80 and over | 27 | 2019 | 59548 | 0.270 |
Why?
|
Case-Control Studies | 12 | 2024 | 22254 | 0.260 |
Why?
|
Colitis, Microscopic | 1 | 2007 | 72 | 0.260 |
Why?
|
Quality Indicators, Health Care | 4 | 2018 | 1804 | 0.260 |
Why?
|
Salivary Proline-Rich Proteins | 2 | 2015 | 5 | 0.260 |
Why?
|
Socioeconomic Factors | 4 | 2019 | 7848 | 0.250 |
Why?
|
Risk Factors | 26 | 2024 | 74886 | 0.250 |
Why?
|
Patient Satisfaction | 2 | 2016 | 3488 | 0.250 |
Why?
|
Mortality | 2 | 2019 | 2909 | 0.250 |
Why?
|
Retrospective Studies | 29 | 2023 | 81659 | 0.250 |
Why?
|
Nutritional Status | 1 | 2014 | 1628 | 0.250 |
Why?
|
Testosterone | 1 | 2016 | 2490 | 0.250 |
Why?
|
Venous Thrombosis | 1 | 2014 | 1321 | 0.240 |
Why?
|
Anemia | 3 | 2022 | 1514 | 0.240 |
Why?
|
Genetic Testing | 2 | 2015 | 3591 | 0.230 |
Why?
|
Amoxicillin | 2 | 2016 | 179 | 0.230 |
Why?
|
Hospital Costs | 1 | 2010 | 956 | 0.230 |
Why?
|
Esophageal Diseases | 2 | 2015 | 167 | 0.230 |
Why?
|
Conflict of Interest | 5 | 2016 | 556 | 0.230 |
Why?
|
Treatment Outcome | 17 | 2020 | 65295 | 0.230 |
Why?
|
Colonic Neoplasms | 2 | 2018 | 2535 | 0.220 |
Why?
|
Atrophy | 7 | 2023 | 1631 | 0.220 |
Why?
|
Proton Pump Inhibitors | 3 | 2017 | 551 | 0.220 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2011 | 957 | 0.220 |
Why?
|
Feces | 5 | 2020 | 1508 | 0.220 |
Why?
|
Predictive Value of Tests | 13 | 2018 | 15424 | 0.220 |
Why?
|
Research Support as Topic | 3 | 2021 | 697 | 0.220 |
Why?
|
Cross Infection | 3 | 2017 | 1426 | 0.210 |
Why?
|
Evidence-Based Medicine | 5 | 2016 | 3700 | 0.210 |
Why?
|
Bronchial Diseases | 2 | 2014 | 151 | 0.210 |
Why?
|
Follow-Up Studies | 14 | 2023 | 39317 | 0.210 |
Why?
|
Informed Consent | 2 | 2019 | 1010 | 0.210 |
Why?
|
Outpatients | 1 | 2010 | 1600 | 0.200 |
Why?
|
Medication Adherence | 1 | 2014 | 2191 | 0.200 |
Why?
|
Time Factors | 13 | 2018 | 40154 | 0.200 |
Why?
|
Focus Groups | 3 | 2014 | 1460 | 0.190 |
Why?
|
Pulmonary Medicine | 2 | 2014 | 223 | 0.190 |
Why?
|
Random Allocation | 2 | 2021 | 2394 | 0.190 |
Why?
|
Developed Countries | 1 | 2024 | 453 | 0.190 |
Why?
|
Mendelian Randomization Analysis | 2 | 2024 | 1040 | 0.190 |
Why?
|
Endoscopy, Digestive System | 2 | 2015 | 358 | 0.190 |
Why?
|
Fellowships and Scholarships | 3 | 2019 | 1135 | 0.190 |
Why?
|
Histamine H2 Antagonists | 2 | 2017 | 169 | 0.190 |
Why?
|
Pulmonary Embolism | 1 | 2014 | 2598 | 0.180 |
Why?
|
Data Collection | 2 | 2017 | 3321 | 0.180 |
Why?
|
Dietetics | 1 | 2020 | 34 | 0.180 |
Why?
|
Education, Medical, Continuing | 3 | 2015 | 829 | 0.180 |
Why?
|
Women's Health | 1 | 2010 | 2082 | 0.180 |
Why?
|
Quality of Health Care | 1 | 2015 | 4306 | 0.180 |
Why?
|
Career Choice | 1 | 2017 | 769 | 0.170 |
Why?
|
Cost-Benefit Analysis | 5 | 2020 | 5537 | 0.170 |
Why?
|
Nephrology | 2 | 2014 | 270 | 0.170 |
Why?
|
Immunologic Tests | 1 | 2020 | 101 | 0.170 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3804 | 0.170 |
Why?
|
Qualitative Research | 2 | 2024 | 3139 | 0.170 |
Why?
|
Early Detection of Cancer | 4 | 2019 | 3236 | 0.170 |
Why?
|
Anticoagulants | 2 | 2015 | 4854 | 0.170 |
Why?
|
Norway | 1 | 2021 | 500 | 0.170 |
Why?
|
Staff Development | 2 | 2015 | 231 | 0.170 |
Why?
|
Documentation | 2 | 2017 | 915 | 0.170 |
Why?
|
Adolescent | 22 | 2024 | 89046 | 0.160 |
Why?
|
Prospective Studies | 18 | 2023 | 54886 | 0.160 |
Why?
|
Income | 3 | 2024 | 1877 | 0.160 |
Why?
|
Cohort Studies | 14 | 2024 | 41718 | 0.160 |
Why?
|
Recurrence | 7 | 2019 | 8504 | 0.160 |
Why?
|
Massachusetts | 5 | 2016 | 8890 | 0.160 |
Why?
|
Autoimmune Diseases | 3 | 2024 | 2255 | 0.160 |
Why?
|
Forecasting | 1 | 2008 | 2936 | 0.160 |
Why?
|
Diagnostic Techniques, Digestive System | 2 | 2016 | 45 | 0.150 |
Why?
|
Tropheryma | 1 | 2018 | 4 | 0.150 |
Why?
|
Gastrointestinal Tract | 3 | 2016 | 837 | 0.150 |
Why?
|
Whipple Disease | 1 | 2018 | 20 | 0.150 |
Why?
|
Nutrition Surveys | 2 | 2016 | 1738 | 0.150 |
Why?
|
Antibodies | 3 | 2017 | 2419 | 0.150 |
Why?
|
Physicians | 4 | 2018 | 4593 | 0.150 |
Why?
|
Body Mass Index | 2 | 2016 | 13048 | 0.150 |
Why?
|
o-Phthalaldehyde | 1 | 2017 | 15 | 0.150 |
Why?
|
Diet Therapy | 1 | 2018 | 150 | 0.140 |
Why?
|
Duodenoscopy | 1 | 2017 | 45 | 0.140 |
Why?
|
Ethylene Oxide | 1 | 2017 | 28 | 0.140 |
Why?
|
Age Factors | 5 | 2019 | 18401 | 0.140 |
Why?
|
Immunoglobulin G | 6 | 2017 | 4560 | 0.140 |
Why?
|
United States | 15 | 2021 | 72971 | 0.140 |
Why?
|
Equipment Reuse | 1 | 2017 | 45 | 0.140 |
Why?
|
Interviews as Topic | 2 | 2017 | 2741 | 0.140 |
Why?
|
Clavulanic Acid | 1 | 2016 | 19 | 0.140 |
Why?
|
Patient Education as Topic | 3 | 2019 | 2337 | 0.140 |
Why?
|
Protein Engineering | 1 | 2021 | 554 | 0.140 |
Why?
|
Duodenoscopes | 1 | 2017 | 43 | 0.140 |
Why?
|
Critical Illness | 1 | 2010 | 2753 | 0.140 |
Why?
|
Patient Care | 2 | 2013 | 628 | 0.140 |
Why?
|
Double-Blind Method | 6 | 2021 | 12451 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2024 | 12250 | 0.130 |
Why?
|
Ataxia | 1 | 2019 | 307 | 0.130 |
Why?
|
Sterilization | 1 | 2017 | 132 | 0.130 |
Why?
|
Feeding Behavior | 1 | 2009 | 3207 | 0.130 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2024 | 1372 | 0.130 |
Why?
|
Dyspepsia | 1 | 2017 | 116 | 0.130 |
Why?
|
Clinical Competence | 3 | 2017 | 4859 | 0.130 |
Why?
|
Prevalence | 9 | 2020 | 15851 | 0.130 |
Why?
|
Flumazenil | 1 | 2016 | 84 | 0.130 |
Why?
|
Tight Junctions | 3 | 2015 | 324 | 0.130 |
Why?
|
IgA Deficiency | 1 | 2016 | 39 | 0.130 |
Why?
|
Equipment Contamination | 1 | 2017 | 183 | 0.130 |
Why?
|
Disinfectants | 1 | 2017 | 131 | 0.130 |
Why?
|
Postoperative Hemorrhage | 1 | 2019 | 418 | 0.130 |
Why?
|
Lactulose | 2 | 2012 | 30 | 0.130 |
Why?
|
Logistic Models | 8 | 2024 | 13284 | 0.130 |
Why?
|
Enterotoxins | 2 | 2015 | 366 | 0.130 |
Why?
|
Atropine | 1 | 2016 | 243 | 0.130 |
Why?
|
Lactobacillus | 1 | 2017 | 212 | 0.130 |
Why?
|
Iohexol | 1 | 2016 | 205 | 0.120 |
Why?
|
Intestine, Large | 1 | 2015 | 69 | 0.120 |
Why?
|
North America | 2 | 2019 | 1287 | 0.120 |
Why?
|
Disinfection | 1 | 2017 | 207 | 0.120 |
Why?
|
Metronidazole | 1 | 2016 | 236 | 0.120 |
Why?
|
Salivary Proteins and Peptides | 1 | 2015 | 48 | 0.120 |
Why?
|
Biomedical Research | 3 | 2021 | 3464 | 0.120 |
Why?
|
Combined Modality Therapy | 3 | 2016 | 8535 | 0.120 |
Why?
|
Health Surveys | 2 | 2016 | 4056 | 0.120 |
Why?
|
Citrulline | 1 | 2015 | 107 | 0.120 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3530 | 0.120 |
Why?
|
Trametes | 1 | 2014 | 2 | 0.120 |
Why?
|
Personality | 1 | 2018 | 559 | 0.120 |
Why?
|
Psychometrics | 1 | 2024 | 3060 | 0.120 |
Why?
|
Injections | 1 | 2018 | 839 | 0.120 |
Why?
|
Malnutrition | 2 | 2012 | 632 | 0.120 |
Why?
|
Gastric Acid | 1 | 2014 | 98 | 0.120 |
Why?
|
Vancomycin Resistance | 1 | 2015 | 125 | 0.120 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2024 | 3449 | 0.120 |
Why?
|
Central Nervous System Diseases | 1 | 2019 | 518 | 0.120 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2420 | 0.120 |
Why?
|
Off-Label Use | 1 | 2016 | 185 | 0.120 |
Why?
|
Prebiotics | 1 | 2014 | 41 | 0.120 |
Why?
|
beta-Alanine | 1 | 2014 | 82 | 0.110 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2016 | 292 | 0.110 |
Why?
|
Crohn Disease | 2 | 2020 | 2295 | 0.110 |
Why?
|
Sex Factors | 3 | 2016 | 10622 | 0.110 |
Why?
|
Stomach Diseases | 1 | 2015 | 134 | 0.110 |
Why?
|
Decision Support Techniques | 2 | 2014 | 2006 | 0.110 |
Why?
|
Bradycardia | 1 | 2016 | 305 | 0.110 |
Why?
|
Private Practice | 3 | 2023 | 154 | 0.110 |
Why?
|
Sensitivity and Specificity | 9 | 2019 | 14672 | 0.110 |
Why?
|
Salicylates | 1 | 2014 | 127 | 0.110 |
Why?
|
Risk Assessment | 8 | 2019 | 24299 | 0.110 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2017 | 793 | 0.110 |
Why?
|
Acute Disease | 2 | 2016 | 7236 | 0.110 |
Why?
|
Liver Function Tests | 1 | 2015 | 526 | 0.110 |
Why?
|
Fertility | 2 | 2010 | 771 | 0.110 |
Why?
|
Esophageal Stenosis | 1 | 2015 | 196 | 0.110 |
Why?
|
Benzocaine | 1 | 2013 | 14 | 0.110 |
Why?
|
Vancomycin | 1 | 2016 | 504 | 0.110 |
Why?
|
Naloxone | 1 | 2016 | 372 | 0.110 |
Why?
|
Lymphocytosis | 1 | 2014 | 121 | 0.110 |
Why?
|
Trypsin Inhibitors | 1 | 2012 | 32 | 0.110 |
Why?
|
Faculty, Medical | 2 | 2015 | 1227 | 0.110 |
Why?
|
Folic Acid Deficiency | 1 | 2014 | 117 | 0.110 |
Why?
|
Therapeutic Irrigation | 1 | 2014 | 297 | 0.110 |
Why?
|
Students, Dental | 1 | 2015 | 171 | 0.110 |
Why?
|
Group Processes | 2 | 2012 | 225 | 0.100 |
Why?
|
False Negative Reactions | 1 | 2014 | 570 | 0.100 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2014 | 119 | 0.100 |
Why?
|
Methylene Blue | 1 | 2013 | 156 | 0.100 |
Why?
|
Food | 2 | 2015 | 766 | 0.100 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2017 | 592 | 0.100 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 3431 | 0.100 |
Why?
|
Education, Dental | 1 | 2015 | 220 | 0.100 |
Why?
|
Comorbidity | 5 | 2024 | 10582 | 0.100 |
Why?
|
Stroke | 1 | 2014 | 9746 | 0.100 |
Why?
|
Enoxaparin | 1 | 2014 | 391 | 0.100 |
Why?
|
Barrett Esophagus | 1 | 2016 | 494 | 0.100 |
Why?
|
Saliva | 1 | 2017 | 853 | 0.100 |
Why?
|
Coronary Angiography | 2 | 2014 | 4525 | 0.100 |
Why?
|
Intubation, Gastrointestinal | 1 | 2013 | 166 | 0.100 |
Why?
|
Cooking | 1 | 2014 | 327 | 0.100 |
Why?
|
Disease Management | 2 | 2020 | 2531 | 0.100 |
Why?
|
Developing Countries | 1 | 2024 | 2911 | 0.100 |
Why?
|
Bacterial Toxins | 2 | 2015 | 922 | 0.100 |
Why?
|
Multimedia | 1 | 2012 | 76 | 0.100 |
Why?
|
Immune Tolerance | 1 | 2021 | 2322 | 0.100 |
Why?
|
Eosinophilic Esophagitis | 1 | 2015 | 205 | 0.100 |
Why?
|
Sickness Impact Profile | 1 | 2013 | 299 | 0.100 |
Why?
|
Mannitol | 1 | 2012 | 176 | 0.100 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2016 | 773 | 0.100 |
Why?
|
Natural Language Processing | 2 | 2017 | 1202 | 0.090 |
Why?
|
Morpholines | 1 | 2014 | 584 | 0.090 |
Why?
|
Genetic Markers | 2 | 2015 | 2602 | 0.090 |
Why?
|
Obesity | 2 | 2022 | 13085 | 0.090 |
Why?
|
Immunomodulation | 1 | 2015 | 548 | 0.090 |
Why?
|
Drug Design | 1 | 2016 | 1045 | 0.090 |
Why?
|
Proteoglycans | 1 | 2014 | 807 | 0.090 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 7121 | 0.090 |
Why?
|
Patient Readmission | 2 | 2015 | 3283 | 0.090 |
Why?
|
Analgesics | 1 | 2018 | 1071 | 0.090 |
Why?
|
Boston | 4 | 2021 | 9360 | 0.090 |
Why?
|
Immunization | 1 | 2015 | 1218 | 0.090 |
Why?
|
Information Dissemination | 2 | 2017 | 1142 | 0.090 |
Why?
|
Problem-Based Learning | 3 | 2012 | 360 | 0.090 |
Why?
|
Intestinal Diseases | 1 | 2015 | 505 | 0.090 |
Why?
|
Employee Discipline | 1 | 1990 | 8 | 0.090 |
Why?
|
Professional Impairment | 1 | 1990 | 7 | 0.090 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 1217 | 0.090 |
Why?
|
Fetal Blood | 1 | 2017 | 1361 | 0.090 |
Why?
|
Students, Medical | 3 | 2015 | 1965 | 0.090 |
Why?
|
Thiophenes | 1 | 2014 | 570 | 0.090 |
Why?
|
Plant Proteins | 1 | 2012 | 376 | 0.090 |
Why?
|
Patient Preference | 1 | 2018 | 947 | 0.090 |
Why?
|
Communication | 3 | 2014 | 3904 | 0.090 |
Why?
|
Prognosis | 8 | 2016 | 29963 | 0.090 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2014 | 281 | 0.090 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2013 | 520 | 0.090 |
Why?
|
Program Evaluation | 4 | 2015 | 2505 | 0.090 |
Why?
|
Prescription Drugs | 1 | 2017 | 635 | 0.090 |
Why?
|
Educational Status | 2 | 2015 | 2511 | 0.090 |
Why?
|
Area Under Curve | 1 | 2014 | 1639 | 0.090 |
Why?
|
Clinical Laboratory Techniques | 1 | 2015 | 746 | 0.080 |
Why?
|
Hypotension | 1 | 2016 | 888 | 0.080 |
Why?
|
Europe | 3 | 2019 | 3432 | 0.080 |
Why?
|
Iatrogenic Disease | 1 | 2013 | 551 | 0.080 |
Why?
|
Guidelines as Topic | 2 | 2016 | 1396 | 0.080 |
Why?
|
Intention | 1 | 2012 | 347 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2018 | 6067 | 0.080 |
Why?
|
Histocompatibility Testing | 2 | 2014 | 717 | 0.080 |
Why?
|
Micronutrients | 2 | 2023 | 390 | 0.080 |
Why?
|
Immunosuppressive Agents | 2 | 2016 | 4210 | 0.080 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2014 | 372 | 0.080 |
Why?
|
Benzimidazoles | 1 | 2014 | 862 | 0.080 |
Why?
|
Musculoskeletal Diseases | 1 | 2015 | 599 | 0.080 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4855 | 0.080 |
Why?
|
Monitoring, Intraoperative | 1 | 2016 | 947 | 0.080 |
Why?
|
Nanoparticles | 1 | 2021 | 1966 | 0.080 |
Why?
|
Pyridones | 1 | 2014 | 819 | 0.080 |
Why?
|
Risk Management | 1 | 2013 | 558 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36582 | 0.080 |
Why?
|
Toll-Like Receptor 4 | 1 | 2012 | 588 | 0.080 |
Why?
|
Fatigue | 1 | 2016 | 1556 | 0.080 |
Why?
|
Pathology | 1 | 2012 | 270 | 0.080 |
Why?
|
Databases, Factual | 2 | 2016 | 8068 | 0.080 |
Why?
|
Diet Surveys | 1 | 2012 | 1160 | 0.080 |
Why?
|
Dehydration | 1 | 2010 | 216 | 0.080 |
Why?
|
Peptides | 1 | 2020 | 4348 | 0.080 |
Why?
|
Leukocytes, Mononuclear | 1 | 2015 | 1854 | 0.080 |
Why?
|
Parturition | 1 | 2012 | 454 | 0.080 |
Why?
|
Secondary Prevention | 2 | 2012 | 1472 | 0.080 |
Why?
|
Lymphocytes | 1 | 2016 | 2605 | 0.080 |
Why?
|
Communicable Diseases | 1 | 2016 | 872 | 0.080 |
Why?
|
Thromboembolism | 1 | 2014 | 1003 | 0.070 |
Why?
|
Triage | 1 | 2015 | 995 | 0.070 |
Why?
|
Propofol | 1 | 2013 | 608 | 0.070 |
Why?
|
Sweden | 2 | 2024 | 1382 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2020 | 10748 | 0.070 |
Why?
|
Lymphoma | 1 | 2017 | 1896 | 0.070 |
Why?
|
Incidence | 5 | 2018 | 21526 | 0.070 |
Why?
|
Heparin | 1 | 2014 | 1636 | 0.070 |
Why?
|
Curriculum | 3 | 2017 | 3786 | 0.070 |
Why?
|
Bronchoscopy | 1 | 2013 | 913 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2019 | 4054 | 0.070 |
Why?
|
Liver Diseases | 1 | 2015 | 1304 | 0.070 |
Why?
|
Risk | 2 | 2011 | 9606 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2017 | 4881 | 0.070 |
Why?
|
Echocardiography, Transesophageal | 1 | 2013 | 1096 | 0.070 |
Why?
|
International Classification of Diseases | 1 | 2013 | 935 | 0.070 |
Why?
|
Erythrocytes | 1 | 2016 | 2411 | 0.070 |
Why?
|
Skin Diseases | 1 | 2015 | 1083 | 0.070 |
Why?
|
Academic Medical Centers | 4 | 2019 | 2783 | 0.070 |
Why?
|
Appointments and Schedules | 1 | 2010 | 443 | 0.070 |
Why?
|
Bacteriological Techniques | 2 | 2018 | 277 | 0.070 |
Why?
|
Cultural Competency | 1 | 2009 | 303 | 0.070 |
Why?
|
Warfarin | 1 | 2014 | 1493 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2019 | 15824 | 0.060 |
Why?
|
Biopsy, Needle | 2 | 2011 | 1615 | 0.060 |
Why?
|
Adaptation, Psychological | 1 | 2017 | 2662 | 0.060 |
Why?
|
Education, Medical | 1 | 2017 | 1746 | 0.060 |
Why?
|
Bacteria | 1 | 2016 | 2212 | 0.060 |
Why?
|
Cultural Diversity | 1 | 2009 | 373 | 0.060 |
Why?
|
Algorithms | 5 | 2023 | 14098 | 0.060 |
Why?
|
Attitude to Health | 1 | 2014 | 2023 | 0.060 |
Why?
|
Patients | 1 | 2012 | 908 | 0.060 |
Why?
|
Parenteral Nutrition | 1 | 2010 | 663 | 0.060 |
Why?
|
Bone Density | 2 | 2010 | 3573 | 0.060 |
Why?
|
Aspirin | 1 | 2017 | 3135 | 0.060 |
Why?
|
Weight Loss | 1 | 2017 | 2716 | 0.060 |
Why?
|
Steroids | 1 | 2010 | 937 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 8048 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2015 | 1660 | 0.060 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2009 | 667 | 0.060 |
Why?
|
Proportional Hazards Models | 5 | 2017 | 12536 | 0.060 |
Why?
|
Reference Values | 1 | 2012 | 4918 | 0.060 |
Why?
|
Terminology as Topic | 1 | 2012 | 1540 | 0.060 |
Why?
|
Bulimia | 1 | 2007 | 405 | 0.060 |
Why?
|
Psychotropic Drugs | 1 | 1990 | 881 | 0.060 |
Why?
|
Vaccination | 1 | 2016 | 3434 | 0.060 |
Why?
|
Pyrazoles | 1 | 2014 | 2028 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2014 | 1389 | 0.060 |
Why?
|
Treatment Failure | 2 | 2007 | 2658 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9660 | 0.050 |
Why?
|
Child | 9 | 2023 | 80771 | 0.050 |
Why?
|
Societies, Medical | 4 | 2021 | 3964 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2023 | 14766 | 0.050 |
Why?
|
Diet, Protein-Restricted | 1 | 2003 | 73 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2011 | 1794 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10254 | 0.050 |
Why?
|
Patient Selection | 1 | 2015 | 4256 | 0.050 |
Why?
|
Population Surveillance | 1 | 2014 | 2594 | 0.050 |
Why?
|
Phenotype | 3 | 2019 | 16718 | 0.050 |
Why?
|
Phyllodes Tumor | 1 | 2003 | 55 | 0.050 |
Why?
|
Contrast Media | 1 | 2016 | 5329 | 0.050 |
Why?
|
Alleles | 1 | 2014 | 6893 | 0.050 |
Why?
|
Multivariate Analysis | 4 | 2019 | 12069 | 0.050 |
Why?
|
Diagnosis, Differential | 5 | 2019 | 12986 | 0.050 |
Why?
|
Motivation | 1 | 2012 | 2021 | 0.050 |
Why?
|
Cross-Sectional Studies | 4 | 2017 | 26325 | 0.050 |
Why?
|
Histocytochemistry | 1 | 2023 | 697 | 0.050 |
Why?
|
Self Report | 1 | 2014 | 3773 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2024 | 18063 | 0.050 |
Why?
|
Cognition | 1 | 2020 | 7059 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2008 | 2920 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20169 | 0.050 |
Why?
|
Community-Acquired Infections | 1 | 2006 | 470 | 0.050 |
Why?
|
Bacterial Proteins | 1 | 2015 | 3834 | 0.050 |
Why?
|
Models, Statistical | 1 | 2016 | 5098 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 2495 | 0.050 |
Why?
|
Probability | 1 | 2007 | 2476 | 0.050 |
Why?
|
Weight Gain | 1 | 2012 | 2360 | 0.050 |
Why?
|
Inpatients | 1 | 2013 | 2563 | 0.050 |
Why?
|
Glycolates | 1 | 2021 | 41 | 0.050 |
Why?
|
Lymphoma, T-Cell | 1 | 2003 | 308 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20741 | 0.050 |
Why?
|
Virus Activation | 1 | 2003 | 322 | 0.050 |
Why?
|
Workload | 1 | 2017 | 849 | 0.050 |
Why?
|
Registries | 3 | 2017 | 8351 | 0.040 |
Why?
|
Internet | 1 | 2012 | 3114 | 0.040 |
Why?
|
Immunotherapy | 1 | 2016 | 4745 | 0.040 |
Why?
|
Nurses | 1 | 1990 | 2501 | 0.040 |
Why?
|
Saccharomyces | 1 | 2020 | 62 | 0.040 |
Why?
|
Educational Measurement | 3 | 2015 | 1259 | 0.040 |
Why?
|
Tablets, Enteric-Coated | 1 | 2019 | 20 | 0.040 |
Why?
|
Pregnancy Outcome | 1 | 2010 | 2972 | 0.040 |
Why?
|
Genotype | 1 | 2014 | 13035 | 0.040 |
Why?
|
Hepatitis B virus | 1 | 2003 | 531 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9245 | 0.040 |
Why?
|
Intestine, Small | 2 | 2019 | 1217 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2009 | 2702 | 0.040 |
Why?
|
Food Contamination | 1 | 2020 | 193 | 0.040 |
Why?
|
Alcoholism | 1 | 1990 | 1980 | 0.040 |
Why?
|
Health Services Research | 2 | 2017 | 1815 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2015 | 13411 | 0.040 |
Why?
|
Animals | 5 | 2021 | 168965 | 0.040 |
Why?
|
Consensus | 2 | 2022 | 3207 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2698 | 0.040 |
Why?
|
Blood Glucose | 1 | 2013 | 6421 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6513 | 0.040 |
Why?
|
Disclosure | 2 | 2014 | 755 | 0.040 |
Why?
|
Anorexia Nervosa | 1 | 2007 | 1363 | 0.040 |
Why?
|
Leadership | 1 | 2007 | 1394 | 0.040 |
Why?
|
Child, Preschool | 3 | 2018 | 42606 | 0.040 |
Why?
|
Chronic Disease | 1 | 2012 | 9362 | 0.040 |
Why?
|
Hepatitis B | 1 | 2003 | 710 | 0.040 |
Why?
|
Uncertainty | 1 | 2022 | 765 | 0.030 |
Why?
|
Research Design | 1 | 2012 | 6210 | 0.030 |
Why?
|
Gases | 1 | 2017 | 205 | 0.030 |
Why?
|
Bacterial Load | 1 | 2017 | 155 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2009 | 3721 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2021 | 2227 | 0.030 |
Why?
|
Gastroscopy | 1 | 2017 | 213 | 0.030 |
Why?
|
Glucocorticoids | 2 | 2019 | 2163 | 0.030 |
Why?
|
Immunoassay | 1 | 2019 | 744 | 0.030 |
Why?
|
Hydrolysis | 1 | 2017 | 645 | 0.030 |
Why?
|
Hospitals | 1 | 2009 | 3883 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5886 | 0.030 |
Why?
|
Folic Acid | 1 | 2022 | 1336 | 0.030 |
Why?
|
Hookworm Infections | 1 | 2015 | 17 | 0.030 |
Why?
|
Illinois | 1 | 2015 | 120 | 0.030 |
Why?
|
Sequence Homology | 1 | 2015 | 197 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6873 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2019 | 454 | 0.030 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2019 | 452 | 0.030 |
Why?
|
Mass Screening | 1 | 2011 | 5456 | 0.030 |
Why?
|
Parotid Gland | 1 | 2015 | 178 | 0.030 |
Why?
|
ROC Curve | 2 | 2015 | 3618 | 0.030 |
Why?
|
Immunity, Innate | 2 | 2019 | 3076 | 0.030 |
Why?
|
Hypertension | 1 | 2014 | 8615 | 0.030 |
Why?
|
Primary Health Care | 1 | 2011 | 4746 | 0.030 |
Why?
|
Canada | 1 | 2019 | 2127 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2016 | 793 | 0.030 |
Why?
|
Enterocytes | 1 | 2015 | 220 | 0.030 |
Why?
|
Eating | 1 | 2020 | 1541 | 0.030 |
Why?
|
Pathology, Clinical | 1 | 2017 | 374 | 0.030 |
Why?
|
Cross Reactions | 1 | 2015 | 828 | 0.030 |
Why?
|
Antibody Specificity | 1 | 2015 | 1062 | 0.030 |
Why?
|
Substance-Related Disorders | 1 | 1990 | 4422 | 0.030 |
Why?
|
Public Health Practice | 1 | 2015 | 220 | 0.030 |
Why?
|
Hordeum | 1 | 2012 | 18 | 0.030 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2003 | 1433 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2017 | 1044 | 0.030 |
Why?
|
U937 Cells | 1 | 2012 | 260 | 0.030 |
Why?
|
Access to Information | 1 | 2015 | 317 | 0.030 |
Why?
|
Dermatitis Herpetiformis | 1 | 2012 | 22 | 0.020 |
Why?
|
Learning | 2 | 2015 | 1754 | 0.020 |
Why?
|
Organizational Case Studies | 1 | 2013 | 301 | 0.020 |
Why?
|
Diet | 1 | 2010 | 8089 | 0.020 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 412 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2012 | 915 | 0.020 |
Why?
|
Hematocrit | 1 | 2013 | 622 | 0.020 |
Why?
|
Needs Assessment | 1 | 2017 | 1141 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2017 | 1196 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2015 | 17608 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2016 | 1188 | 0.020 |
Why?
|
Self Efficacy | 1 | 2015 | 643 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4026 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2448 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2014 | 996 | 0.020 |
Why?
|
Nutritional Support | 1 | 2012 | 178 | 0.020 |
Why?
|
Metagenomics | 1 | 2014 | 473 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2015 | 1716 | 0.020 |
Why?
|
Heart Failure | 1 | 2014 | 11877 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2350 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1641 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2015 | 3052 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1405 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13491 | 0.020 |
Why?
|
Epitopes | 1 | 2015 | 2526 | 0.020 |
Why?
|
Intestines | 1 | 2018 | 1905 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3414 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2015 | 2105 | 0.020 |
Why?
|
Incidental Findings | 1 | 2014 | 698 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 588 | 0.020 |
Why?
|
Pregnancy | 1 | 2010 | 30238 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2012 | 2745 | 0.020 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2012 | 582 | 0.020 |
Why?
|
Colitis | 1 | 2016 | 1238 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2666 | 0.020 |
Why?
|
Patient Admission | 1 | 2015 | 1364 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4405 | 0.020 |
Why?
|
Malpractice | 1 | 2013 | 561 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2003 | 4268 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22350 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2013 | 939 | 0.020 |
Why?
|
Seasons | 1 | 2012 | 1523 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6310 | 0.020 |
Why?
|
Program Development | 1 | 2013 | 1298 | 0.020 |
Why?
|
Vaccines | 1 | 2015 | 842 | 0.020 |
Why?
|
Faculty | 1 | 2009 | 383 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2011 | 1864 | 0.020 |
Why?
|
Feedback | 1 | 2009 | 797 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2013 | 1278 | 0.020 |
Why?
|
Family | 1 | 2016 | 3210 | 0.020 |
Why?
|
Endoscopy | 1 | 2015 | 1854 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1512 | 0.010 |
Why?
|
Esophageal Neoplasms | 1 | 2015 | 1661 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12790 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 16036 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2824 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4280 | 0.010 |
Why?
|
Infant | 2 | 2018 | 36485 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2015 | 9551 | 0.010 |
Why?
|
Headache | 1 | 2011 | 1261 | 0.010 |
Why?
|
Personal Satisfaction | 1 | 2007 | 643 | 0.010 |
Why?
|
Patient Discharge | 1 | 2015 | 3467 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3561 | 0.010 |
Why?
|
Mentors | 1 | 2007 | 672 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2516 | 0.010 |
Why?
|
Mice | 2 | 2021 | 81912 | 0.010 |
Why?
|
Cytokines | 1 | 2015 | 7446 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10393 | 0.010 |
Why?
|
Calcium | 1 | 2012 | 5792 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15567 | 0.010 |
Why?
|
Vitamin D | 1 | 2012 | 3312 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2003 | 1836 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2003 | 862 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2012 | 14476 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12823 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9464 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18330 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2003 | 21178 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 1990 | 2188 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 22361 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23621 | 0.010 |
Why?
|
Liver | 1 | 2003 | 7578 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2003 | 9410 | 0.000 |
Why?
|